BRCA


Also found in: Medical, Acronyms, Wikipedia.

BRCA

n.
Either of two tumor suppressor genes (BRCA1 or BRCA2) that are associated with an increased risk of developing familial breast and ovarian cancer when inherited in a mutated state.

[br(east) ca(ncer).]
References in periodicals archive ?
First of all, the company clearly states on its website that it screens for only three of the more prevalent BRCA breast and ovarian cancer mutations, and emphasizes that there are hundreds of potentially carcinogenic mutations in the BRCA1 and BRCA2 genes for which it does not test.
So for years, doctors have advised BRCA carriers to have their ovaries removed between the ages of 35 and 40, or when women are finished having children.
'Women should have their family history assessed to help make sure that clinicians identify the small number of women with BRCA mutations," Dr.
[12] We therefore describe a programme for genetic counselling and BRCA testing developed in a resource-constrained environment, how it evolved over time and the rates of BRCA mutation detection and family follow-up achieved.
Patients with cancers linked to BRCA mutations saw the most substantial improvement.
Dentro de este grupo de genes estan los denominados BRCA 1 y BRCA2 (por sus siglas en ingles breast related cancer allele 1 y 2), los cuales estan asociados a una mayor presentacion de cancer de mama y ovario y contribuyen al 90 % de los canceres de ovario hereditarios y por lo menos al 50 % de los mamarios correspondientes (7-10).
Keywords: BRCA mutation, preimplantation genetic diagnosis, human reproduction, couples, genetic inheritance
"Breast cancer is very prevalent, but the BRCA founder mutations are rare, occurring in less than 1% of all women," explained task force member Dr.
HRR gene mutations occur in approximately 25% of men diagnosed with mCRPC within which BRCA 1/2 and ATM form the majority.
Roy Baynes, Senior Vice President and Head of Global Clinical Development, Chief Medical Officer, MSD Research Laboratories, said: Advances in understanding the role of BRCA mutations and PARP inhibition have fundamentally changed how physicians can treat this aggressive type of cancer.
Once fully recovered, and with no useful book available to help BRCA mutation carriers like myself, I dedicated my time to writing a book on the BRCA gene.